Anti-SOX10 antibody (400-450) {FITC}

Référence NB-22-59920-100

Conditionnement : 100ug

Contactez votre distributeur local :


Téléphone : +1 850 650 7790

General Info

Host: Rabbit
Applications: ELISA/IHC/IP/WB
Reactivity: Human/Monkey
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-SOX10 (400-450) is suitable for use in ELISA, Immunohistochemistry, Immunoprecipitation and Western Blot research applications.
Clonality: Polyclonal
Conjugation: FITC
Isotype: IgG
Purification: Affinity Purified
Concentration: 0.55-0.75 µg/µl
Dilution Range: WB: 1:500
DB: 1:10, 000
ELISA: 1:10, 000
IP: 1:150
IHC: 1:50-1:100
Storage Instruction: Store at-20°C for long term storage. Avoid freeze-thaw cycles.

Information

Gene Symbol: SOX10
Gene ID: 6663
Uniprot ID: SOX10_HUMAN
Immunogen Region: 400-450
Immunogen: Synthetic peptide taken within amino acid region 400-450 on human Transcription Factor SOX-10 protein.

Description

Tissue Specificity Expressed in fetal brain and in adult brain, heart, small intestine and colon.
Function Transcription factor that plays a central role in developing and mature glia. Specifically activates expression of myelin genes, during oligodendrocyte (OL) maturation, such as DUSP15 and MYRF, thereby playing a central role in oligodendrocyte maturation and CNS myelination. Once induced, MYRF cooperates with SOX10 to implement the myelination program. Transcriptional activator of MITF, acting synergistically with PAX3. Transcriptional activator of MBP, via binding to the gene promoter.
Protein Name Transcription Factor Sox-10
Database Links Reactome: R-HSA-9619665
Reactome: R-HSA-9764302
Cellular Localisation Cytoplasm
Nucleus
Mitochondrion Outer Membrane
Peripheral Membrane Protein
Cytoplasmic Side
Alternative Antibody Names Anti-Transcription Factor Sox-10 antibody
Anti-SOX10 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance